Evidence map›Paper›PMID 20962044›Full record

ArticleMolecular endocrinology (Baltimore, Md.)2010

Cytokine and progesterone receptor interplay in the regulation of MUC1 gene expression.

Neeraja Dharmaraj, Peng Wang, Daniel D Carson

Open access · bronzeAbstract read
In one paragraph

Article in Molecular endocrinology (Baltimore, Md.), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. The Role of Mucins in Esophageal Inflammatory Diseases.Journal of personalized medicine · 2026
    Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. MUC1 (CD227): a multi-tasked molecule.Cellular and molecular life sciences : CMLS · 2015
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. The role of inflammation for a successful implantation.American journal of reproductive immunology (New York, N.Y. : 1989) · 2014
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Neeraja DharmarajDepartment of Biological Sciences, University of Delaware, Newark, Delaware 19716, USA.
Peng Wang
Daniel D Carson
University of Delaware · USRice University · US

Funding

GLYCOPROTEIN MARKERS OF UTERINE RECEPTIVITYR01HD029963 · NICHD · UNIVERSITY OF DELAWARE · PI CARSON, DANIEL D. · 1999 to 2010
$2.1M
GLYCOPROTEIN MARKERS OF UTERINE RECEPTIVITYU01HD029963 · NICHD · UNIVERSITY OF TEXAS MD ANDERSON CAN CTR · PI CARSON, DANIEL D. · 1993 to 2005
$810k
NICHD NIH HHS HD 29963NICHD NIH HHS R01 HD029963NICHD NIH HHS U01 HD029963
6 · The paper itself

Abstract

Mucin 1 (MUC1), a transmembrane mucin expressed at the apical surface of uterine epithelia, is a barrier to microbial infection and enzymatic attack. MUC1 loss at implantation sites appears to be required to permit embryo attachment and implantation in most species. MUC1 expression is regulated by progesterone (P) and proinflammatory cytokines, including TNFα and interferon γ (IFNγ). TNFα and IFNγ are highly expressed in uterine tissues under conditions where MUC1 expression is also high and activate MUC1 expression via their downstream transcription factors, nuclear factor (NF) κB and signal transducers and activators of transcription. P receptor (PR) regulates MUC1 gene expression in a PR isoform-specific fashion. Here we demonstrate that interactions among PR isoforms and cytokine-activated transcription factors cooperatively regulate MUC1 expression in a human uterine epithelial cell line, HES. Low doses of IFNγ and TNFα synergistically stimulate MUC1 promoter activity, enhance PRB stimulation of MUC1 promoter activity and cooperate with PRA to stimulate MUC1 promoter activity. Cooperative stimulation of MUC1 promoter activity requires the DNA-binding domain of the PR isoforms. MUC1 mRNA and protein expression is increased by cytokine and P treatment in HES cells stably expressing PRB. Using chromatin immunoprecipitation assays, we demonstrate efficient recruitment of NFκB, p300, SRC3 (steroid receptor coactivator 3), and PR to the MUC1 promoter. Collectively, our studies indicate a dynamic interplay among cytokine-activated transcription factors, PR isoforms and transcriptional coregulators in modulating MUC1 expression. This interplay may have important consequences in both normal and pathological contexts, e.g. implantation failure and recurrent miscarriages.

Indexed as

Cell LineDNA-Binding ProteinsDose-Response Relationship, DrugEpithelial CellsFemaleGene Expression RegulationHumansInterferon-gammaMucin-1ProgesteronePromoter Regions, GeneticProtein IsoformsReceptors, ProgesteroneRNA, MessengerTranscription FactorsTumor Necrosis Factor-alphaDNA-Binding ProteinsInterferon-gammaMUC1 protein, humanMucin-1ProgesteroneProtein IsoformsReceptors, ProgesteroneRNA, MessengerTranscription FactorsTumor Necrosis Factor-alpha

Identifiers

PMID20962044
PMCPMC2999481
OpenAlexW1989645416

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.